Table 1.
Clinical characteristics of the patients
n = 104 | |
Boy : Girl | 73 : 31 |
Age at onset of NS (years) | 4.85 ± 3.87 |
Age at first flu vaccination (years) | 7.76 ± 5.10 |
Observation period (years) | 2.64 ± 2.20 |
Renal histopathology | |
MC | 62 (59.6%) |
FSGS | 10 (9.6 %) |
DMH | 7 (6.7 %) |
No history of renal biopsy | 25 (24.0%) |
Past history of NS type | |
SRNS | 26 (25.2%) |
FRNS/SDNS | 87 (83.7%) |
From day – 180 ~ + 180 | |
Total number of NS relapses (times) | 261 |
Total number of flu vaccinations (times) | 208 |
Immunosuppressants at flu vaccination | |
No | 43 (20.7%) |
Yes | 165 (79.3%) |
CsA | 104 (50.0%) |
MMF | 40 (19.2%) |
MZR | 31 (14.9%) |
CPM | 5 (2.4%) |
Tac | 2 (1.0%) |
RTX | 6 (2.9%) |
PSL | 49 (23.6%) |
SRNS Steroid resistance nephrotic syndrome, FRNS Frequent relapsing nephrotic syndrome, SDNS Steroid dependence nephrotic syndrome, MC Minimal change, FSGS Focal segmental glomerulosclerosis, DMH Diffuse mesangial hypercellularity, CsA Cyclosporine, MMF Mycophenolate Mofetil, MZR Mizoribine, CPM Cyclophosphamide, Tac Tacrolimus, RTX Rituximab, PSL; prednisolone